Dr. John Powderly Heads Discussion Group at openEHR International and HL7’s 2026 “Converge and Collaborate” Meeting

Converge and Collaborate – 5/14/26

On May 12^th and 13^th in Dublin, Ireland, openEHR International and HL7 (Health Level Seven) hosted their second annual in-person meeting called “Converge and Collaborate”.  With an overall focus on cancer treatment support, this meeting also had the broader aim of increasing the collaborative agenda at the heart of these two organizations, which is improving interoperability for healthcare data exchange.

Dr. John Powderly, President and CEO of both Carolina BioOncology Institute and BioCytics, led a working group discussion around the idea of the convergence of Clinical Research and Informatics. He was also able to explain to an interested audience about the openEHR Affiliate Program, which allows any country or specific field in the medical/health sciences to form a group as part of openEHR International.  These Affiliate Groups help with digital transformation initiatives in all areas where clinical data standards are used or needed.

Dr. Powderly Keynote Speaker at “Hope is Not a Workflow” Symposium

Hope is Not a Workflow – 3/25/26

Dr. Powderly was recently a Keynote Speaker at an event organized by “Hope is Not a Workflow” cell and gene therapy (C&GT) stakeholder collective partnership. Taking place on March 25, 2026, in Research Triangle Park, the daylong symposium focused on advancing manufacturing for C&GT.

Dr. Powderly’s Episodes on the “TIL Talks” Podcast

TIL Talks by Chris White – 2/13/26

Dr. Powderly has been a guest on the podcast “TIL Talks” with host Chris White, a mucosal melanoma survivor, on several occasions over the past few months. Topics discussed include cell therapy, neoantigens, tumor infiltrating lymphocytes, checkpoint inhibitors, clinical trials, and patient awareness, among many other points of conversation related to cancer and cancer treatments.
Please see the list of episodes in the article available via the link below that provides the subject of each conversation and a link to a YouTube video recording of the full-length podcasts.

BioCytics Successfully Completes a Key Regulatory Milestone with Recent FDA INTERACT Meeting

BioCytics INTERACT Meeting – 11/18/25

Huntersville, NC, November 18, 2025—BioCytics is pleased to announce  they successfully reached a regulatory milestone for de-risking clinical development plans with a productive FDA INTERACT meeting during which they discussed manufacturing immune cell therapies at the point of care.

Dr. Powderly Discusses TILs and Cell and Gene Therapy on the “TIL Talks” Podcast

TIL Talks by Chris White – 7/28/25

Listen to Dr. Powderly as he talks with podcast host Chris White about advancements in immunotherapy, with a focus on Peripheral Tumor Infiltrating Lymphocytes (TILs) and their potential for use in cancer treatment. Chris White is a Mucosal Melanoma survivor who has created the podcast called “TIL Talks”, in which he holds one-on-one conversations with patient recipients, caregivers, and industry leaders who have experienced first-hand the curative possibilities of TILs and/or cell and gene therapies. Over the next few months, Dr. Powderly and Chris White will engage in a total of four conversations.

You can hear the first one on YouTube or Spotify using the links below. Look for Episode #12. Then, come back to our News section over the next few weeks to access new links as the next interviews get released.

In this first session, Dr. Powderly discusses his experience as an oncologist and the efforts and clinical trials that are ongoing at Carolina BioOncology. He and Chris then discuss the importance of cell therapy and the need for expanded access to clinical trials. They also highlight the importance of patient advocacy and patients being active in their own care efforts. Finally, they discuss the future of cancer therapies.